Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial
Karyopharm Therapeutics Inc
Mrinal M Gounder; Albiruni Abdul Razak; Neeta Somaiah; Sant Chawla; Javier Martin-Broto; Giovanni Grignani; Scott M Schuetze; Bruno Vincenzi; Andrew J Wagner; Bartosz Chmielowski; Robin L Jones; Richard F Riedel; Silvia Stacchiotti; Elizabeth T Loggers; Kristen N Ganjoo; Axel Le Cesne; Antoine Italiano; Xavier Garcia Del Muro; Melissa Burgess; Sophie Piperno-Neumann; Christopher Ryan; Mary F Mulcahy; Charles Forscher; Nicolas Penel; Scott Okuno; Anthony Elias; Lee Hartner; Tony Philip; Thierry Alcindor; Bernd Kasper; Peter Reichardt; Lore Lapeire; Jean-Yves Blay; Christine Chevreau; Claudia Maria Valverde Morales; Gary K Schwartz; James L Chen; Hari Deshpande; Elizabeth J Davis; Garth Nicholas; Stefan Gröschel; Helen Hatcher; Florence Duffaud; Antonio Casado Herráez; Roberto Diaz Beveridge; Giuseppe Badalamenti; Mikael Eriksson; Christian Meyer; Margaret von Mehren; Brian A Van Tine; Katharina Götze; Filomena Mazzeo; Alexander Yakobson; Aviad Zick; Alexander Lee; Anna Estival Gonzalez; Andrea Napolitano; Mark A Dickson; Dayana Michel; Changting Meng; Lingling Li; Jianjun Liu; Osnat Ben-Shahar; Dane R Van Domelen; Christopher J Walker; Hua Chang; Yosef Landesman; Jatin J Shah; Sharon Shacham; Michael G Kauffman; Steven Attia